ATE146967T1 - Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern - Google Patents

Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern

Info

Publication number
ATE146967T1
ATE146967T1 AT92921364T AT92921364T ATE146967T1 AT E146967 T1 ATE146967 T1 AT E146967T1 AT 92921364 T AT92921364 T AT 92921364T AT 92921364 T AT92921364 T AT 92921364T AT E146967 T1 ATE146967 T1 AT E146967T1
Authority
AT
Austria
Prior art keywords
gamma
ifn
transplant recipients
treat infections
treatment
Prior art date
Application number
AT92921364T
Other languages
English (en)
Inventor
Christine Czarniecki
Jon B Klein
A David Slater
Gerald Sonnenfeld
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE146967T1 publication Critical patent/ATE146967T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92921364T 1991-10-07 1992-10-05 Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern ATE146967T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/773,382 US5248499A (en) 1991-10-07 1991-10-07 Control of microbial infections in transplant patients

Publications (1)

Publication Number Publication Date
ATE146967T1 true ATE146967T1 (de) 1997-01-15

Family

ID=25098084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921364T ATE146967T1 (de) 1991-10-07 1992-10-05 Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern

Country Status (20)

Country Link
US (1) US5248499A (de)
EP (1) EP0607258B1 (de)
JP (1) JP3467037B2 (de)
KR (1) KR100262063B1 (de)
AT (1) ATE146967T1 (de)
AU (1) AU666138B2 (de)
CA (1) CA2119236C (de)
DE (1) DE69216419T2 (de)
DK (1) DK0607258T3 (de)
ES (1) ES2097929T3 (de)
FI (1) FI941552L (de)
GR (1) GR3022672T3 (de)
HU (1) HU226455B1 (de)
IL (1) IL103341A (de)
NO (1) NO313576B1 (de)
NZ (1) NZ244615A (de)
PH (1) PH30211A (de)
PT (1) PT100932B (de)
WO (1) WO1993006847A1 (de)
ZA (1) ZA927677B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724838D0 (en) * 1997-11-26 1998-01-21 Franks Christopher R Compositions
EP1221976A4 (de) * 1999-09-28 2003-12-03 Amarillo Biosciences Inc Ifn-gama in niedriger dosierung zur behandlung von erkrankungen
EP1318834A2 (de) * 2000-09-12 2003-06-18 Genetrol Biotherapeutics, Inc. Zusammensetzung, die eine mischung von menschlichen zytokinen enthält, sowie verfahren für ihre herstellung
US20020150541A1 (en) * 2000-09-12 2002-10-17 Gene Trol Biotherapeutics, Inc. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
EP1351707B9 (de) * 2001-01-09 2012-01-25 Baylor Research Institute Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
IL160761A0 (en) * 2001-10-19 2004-08-31 Isotechnika Inc Novel cyclosporin analog microemulsion preconcentrates
WO2005065079A2 (en) * 2003-11-10 2005-07-21 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20070116678A1 (en) * 2005-11-23 2007-05-24 Hsing-Wen Sung Medical device with living cell sheet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2237767A (en) * 1989-11-09 1991-05-15 Cosgrove Tools Ltd Moulding machine ejector devices

Also Published As

Publication number Publication date
EP0607258B1 (de) 1997-01-02
DE69216419T2 (de) 1997-06-26
WO1993006847A1 (en) 1993-04-15
PH30211A (en) 1997-02-05
HU9400984D0 (en) 1994-07-28
PT100932A (pt) 1993-10-29
ZA927677B (en) 1994-04-07
PT100932B (pt) 1999-07-30
KR100262063B1 (ko) 2000-07-15
NO941242D0 (no) 1994-04-06
DE69216419D1 (de) 1997-02-13
IL103341A0 (en) 1993-03-15
GR3022672T3 (en) 1997-05-31
FI941552A7 (fi) 1994-04-05
NO941242L (no) 1994-06-03
FI941552A0 (fi) 1994-04-05
CA2119236C (en) 2007-05-22
DK0607258T3 (da) 1997-04-14
FI941552L (fi) 1994-04-05
AU666138B2 (en) 1996-02-01
EP0607258A1 (de) 1994-07-27
HU226455B1 (en) 2008-12-29
HUT67008A (en) 1995-01-30
IL103341A (en) 1997-11-20
CA2119236A1 (en) 1993-04-15
NZ244615A (en) 1997-06-24
JP3467037B2 (ja) 2003-11-17
NO313576B1 (no) 2002-10-28
ES2097929T3 (es) 1997-04-16
JPH07500106A (ja) 1995-01-05
KR940702735A (ko) 1994-09-17
US5248499A (en) 1993-09-28
AU2762292A (en) 1993-05-03

Similar Documents

Publication Publication Date Title
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DK0675708T3 (da) Farmaceutiske og dermokosmetiske sammensætninger indeholdende heste-colostrum.
IL189629A0 (en) Compositions containing human ctla-4 antibodies
DE60026561D1 (de) Suppressorzellen zur prävention und behandlung von immunantworten bei transplantationen
ATE123226T1 (de) Verwendung von anti-tnf-antikörpern als arzneimittel bei der behandlung von ischämien und deren folgen.
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
ATE146967T1 (de) Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern
ES2125976T3 (es) Otros derivados de indol con accion antiviral.
DK1675603T3 (da) Anvendelse af probiotiske bakterier i behandling af infektion
DE69008258D1 (de) S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.
FR2491334B1 (de)
ATE238990T1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ZA98420B (en) Use of pramipexole in the treatment of restless legs syndrome.
DE69023006D1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DK0863981T3 (da) Detektering, forebyggelse og behandling af papillomatous digital dermatitis
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
ATE96039T1 (de) Arzneimittel und ihre verwendung zur behandlung von parasitosen.
TR199800850T2 (xx) Kan� d�zenleyici bile�imler.
MY110041A (en) Composition and method of treating hepatitis c
DE59405845D1 (de) Verwendung von 2-Methylamino-2-phenylcyclohexanon zur Behandlung von Infektionen und zur Immunmodulation
ATE283063T1 (de) Allogene und xenogene transplantation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification